GB9703139D0 - Method of determining susceptibility to late-onset alzheimer's disease - Google Patents

Method of determining susceptibility to late-onset alzheimer's disease

Info

Publication number
GB9703139D0
GB9703139D0 GBGB9703139.7A GB9703139A GB9703139D0 GB 9703139 D0 GB9703139 D0 GB 9703139D0 GB 9703139 A GB9703139 A GB 9703139A GB 9703139 D0 GB9703139 D0 GB 9703139D0
Authority
GB
United Kingdom
Prior art keywords
late
disease
onset alzheimer
determining susceptibility
susceptibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9703139.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB9703139.7A priority Critical patent/GB9703139D0/en
Publication of GB9703139D0 publication Critical patent/GB9703139D0/en
Priority to PCT/GB1998/000467 priority patent/WO1998036091A1/en
Priority to AU62230/98A priority patent/AU6223098A/en
Pending legal-status Critical Current

Links

GBGB9703139.7A 1997-02-14 1997-02-14 Method of determining susceptibility to late-onset alzheimer's disease Pending GB9703139D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9703139.7A GB9703139D0 (en) 1997-02-14 1997-02-14 Method of determining susceptibility to late-onset alzheimer's disease
PCT/GB1998/000467 WO1998036091A1 (en) 1997-02-14 1998-02-13 Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies
AU62230/98A AU6223098A (en) 1997-02-14 1998-02-13 Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9703139.7A GB9703139D0 (en) 1997-02-14 1997-02-14 Method of determining susceptibility to late-onset alzheimer's disease

Publications (1)

Publication Number Publication Date
GB9703139D0 true GB9703139D0 (en) 1997-04-02

Family

ID=10807706

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9703139.7A Pending GB9703139D0 (en) 1997-02-14 1997-02-14 Method of determining susceptibility to late-onset alzheimer's disease

Country Status (1)

Country Link
GB (1) GB9703139D0 (en)

Similar Documents

Publication Publication Date Title
IL112050A0 (en) Methods of inhibiting alzheimer's disease
PL348226A1 (en) Compounds for the antemortem diagnosis of alzheimer's disease and in vivo
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
ZA9410041B (en) Use of PLA2 inhibitors as treatment for Alzheimer's Disease
AU8897298A (en) System and method of noninvasevely determining a patient's susceptibility to arrhythmia
EP1043991A4 (en) Treatment for alzheimer's disease
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
GB9316727D0 (en) Models of alzheimers's disease
EP1007048A4 (en) Identification of agents for use in the treatment of alzheimer's disease
HUP9603272A3 (en) An oral composition enhancing brain's activity
GB9516214D0 (en) Amelioration of dupuytren's disease
IL127146A0 (en) Transdermal propentofylline compositions for the treatment of alzheimer's disease
ZA989365B (en) Preparation for treating alzheimer's disease
EP1029039A4 (en) Non-transgenic animal model of alzheimer's disease
TR199701051A3 (en) Preparation process of 2 '-Fluoro-5-methyl--1-arabino-furanosyluridine
ITMI942271A0 (en) IMPROVED EQUIPMENT FOR USE OF BICYCLES IN WATER
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
HUP0002003A2 (en) Process and reagent-kit for determining of 5'-nucleotidase activity
EP0842189A4 (en) Early onset alzheimer's disease gene and gene products
GB9703139D0 (en) Method of determining susceptibility to late-onset alzheimer's disease
EP0728216A4 (en) Detection of alzheimer's disease and other diseases using an improved photoaffinity labeling method
GB9709416D0 (en) Methods for treatment of alzheimer's disease using azaspiranes
AU6223098A (en) Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies
GB9323826D0 (en) Diagnosis of alzheimer's disease
GB9703939D0 (en) Method of determining susceptibilty to late-onset alzheimer's disease and dementia with lewy bodies